Country Report Our last report was in 2009-2010 when the “social emergency crisis” happened. What would you say have been the most important changes in the health system since that time? The main cause of the crisis was a drastic increase in the number of recobros (individuals asking to be reimbursed for…
Juan Carlos Fierro As a means of introduction, could you describe your background and how you became involved with Nutripharma in the first place? Nutripharma is a 12-year-old family company created by my father, Luis Fierro. After working as a sales representative for various pharmaceutical companies for many years, he began his own…
EndoCeutics Dr. Fernand Labrie, long before becoming CEO of EndoCeutics, discovered and developed medical castration with GnRH agonists, a breakthrough treatment that quickly replaced surgical castration back in the early 1980s. Along with other discoveries, he founded EndoResearch in 1985 to further his research. After billions in revenue from treatments developed…
clinical trials You are the CEO of GCP CMIC ClinPlus in addition to R&G PharmaStudies, and before that you headed a number of companies as well. Could you introduce yourself and all the many moving parts you lead to our readers? To begin with, I was a physician for 10 years before…
Goodyear Minister for Science shares with us how the Canadian Government has taken a different approach to funding innovationand the benefits it has reaped in the pharma industry as a whole in the country. You became Minister of State for Science and Technology in 2008, a position that had previously not…
Juan Diego Sr. Gutierrez, when we interviewed your father in 2010, he described to us the strong potential of the medical industry in Colombia in the future. Since that time, would you say that Siplas has been able to take advantage of that potential? And if so, how? Siplas has been growing…
Espíndola International Consultants An expert in trade and regulatory issues relating to the pharmaceutical industry in Colombia, the senior partner of Espíndola International Consultants offers his opinions on the steps taken by the Colombian authorities to improve quality and reduce corruption in the sector, as well as discussing the steps to maintain cost containment…
Primecore Mr. Callaghan, you have had quite a long and prestigious career in the pharmaceutical industry, with experience overseeing manufacturing programs for giants such as Amgen, BMS and Merck. Can you give us an overview of your career path? My background is in chemical engineering—I am a process engineer. When I…
maintenance Mr. O’Neill, you have been managing director of this company for 17 years. How have you evolved the business over that period? ESS was founded in 1991, and I joined the business in 1996. The company’s initial vision was to provide flexibility to the maintenance market in Ireland and its…
Steripack Mr. Moore, can you please introduce our readers to yourself and to SteriPack? SteriPack was founded in Clara, Ireland, in 1994. When I joined the organization 18 years ago, we had perhaps eight people on staff. Today, our headcount approaches 400. We have four production sites spread across Ireland, Poland,…
Takeda Pharma GmbH Can you give our readers a snapshot of the scope of Takeda’s operations and the organizational structure within Austria? Takeda in Austria is a top-ten player with a turnover of roughly €80 million, according to IMS figures. In primary care markets we focus on core therapeutic areas such as cardiovascular…
See our Cookie Privacy Policy Here
